Department of Gastroenterology and Hepatology, University Hospital Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium.
Int J Mol Sci. 2013 Oct 1;14(10):19867-90. doi: 10.3390/ijms141019867.
Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and hepatocyte injury and constitutes hepatic manifestation of the metabolic syndrome. The pathogenesis of NASH is complex and implicates cross-talk between different metabolically active sites, such as liver and adipose tissue. Obesity is considered a chronic low-grade inflammatory state and the liver has been recognized as being an "immunological organ". The complex role of the immune system in the pathogenesis of NASH is currently raising great interest, also in view of the possible therapeutic potential of immunotherapy in NASH. This review focuses on the disturbances of the cells constituting the innate and adaptive immune system in the liver and in adipose tissue.
非酒精性脂肪性肝炎(NASH)的特征是存在脂肪变性、炎症和肝细胞损伤,是代谢综合征的肝脏表现。NASH 的发病机制复杂,涉及不同代谢活跃部位(如肝脏和脂肪组织)之间的相互作用。肥胖被认为是一种慢性低度炎症状态,肝脏已被认为是一个“免疫器官”。鉴于免疫疗法在 NASH 中的可能治疗潜力,免疫系统在 NASH 发病机制中的复杂作用目前引起了极大的兴趣。这篇综述重点介绍了肝脏和脂肪组织中固有和适应性免疫系统组成细胞的紊乱。